![[Partner Post] OD Perspective: From Specialty to Standard of Care in Practice](https://www.healthmkts.com/wp-content/uploads/2026/06/Partner-Post-OD-Perspective-From-Specialty-to-Standard-of-Care.jpg "[Partner Post] OD Perspective: From Specialty to Standard of Care in Practice")
In recognition of Myopia Awareness Week, EssilorLuxottica is continuing the conversation with a closer look at how myopia management is taking shape in everyday practice.
In this Q&A, Jason Lake, OD, General Manager, PERC & Opti-Port, shares a real-world perspective on how the category has evolved—from a specialized offering to a standard of care1—and what that shift means for patient conversations and clinical workflows.
Jason Lake, OD, General Manager, PERC & Opti-Port
Q. From a practice perspective, how are you seeing myopia management come to life?
A. I think the biggest shift is that myopia management is now considered a standard of care1, where it was once seen as more of a specialty. As a result, the conversation—both with patients and across providers—is evolving, ultimately elevating the level of care we deliver to young patients.
Q. What impact are solutions like Essilor® Stellest® Lenses having in your members’ practices?
An innovation like Essilor® Stellest® Lenses helps make myopia management more accessible, practical, and scalable for everyday practice.2,3
Due to the prescription range, strong safety profile, and ease of use4,3 Essilor® Stellest® Lenses have removed many of the previous limitations associated with other myopia control options.5 For many patients and families, spectacle lenses are familiar, non-invasive, and easy to adopt,4,3 which can make the myopia management conversation more approachable.
From a clinical workflow standpoint, the simplicity, ease of use, and efficacy4,3 make this innovation a fantastic option for children at risk for myopia progression. It allows eye care professionals to move from simply correcting vision to actively managing progression in a way that fits naturally into pediatric eye care.2,3
Q. What insights would you share with eye care professionals who are considering offering myopia management in their practice?
A. The reality is that with today’s technology, myopia management is the new standard of care.1 Fitting a pair of glasses is already part of correcting vision—this simply builds on that, addressing both the practical issue of blur and the more complex challenge of myopia progression.2,3
Additional Resources:
References:
-
World Council of Optometry – Standard of Care for Myopia Management
World Council of Optometry. The standard of care for myopia management by optometrists [Internet]. St. Louis (MO): World Council of Optometry; 2021 [cited 2026 May 21]. Available from: https://myopia.worldcouncilofoptometry.info/
standard-of-care/ - Compared to single vision lenses. Results from a prospective, randomized, double masked, multicenter U.S. clinical trial in myopic children aged 6–12 years at initiation of treatment.
- Essilor International, data on file (2025)
- The Essilor® Stellest® spectacle lens demonstrated an acceptable safety profile and positive benefit–risk profile. Results from a prospective, randomized, double-masked, multicenter U.S. clinical trial in myopic children aged 6–12 years at initiation of treatment.
- U.S. Food and Drug Administration. FDA authorizes marketing of first eyeglass lenses to slow progression of pediatric myopia [Internet]. Silver Spring (MD): U.S. Food and Drug Administration; 2025 Sep [cited 2026 May 20]. Available from: https://www.fda.gov/news-events/press-announcements/fda-authorizes-marketing-first-eyeglass-lenses-slow-progression-pediatric-myopia
